TipRanks
Samjin Pharmaceutical Co., Ltd. (KR:005500)
:005500
South Korea Market
005500
Samjin Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Samjin Pharmaceutical Co., Ltd. (005500) Income Statement

― Followers

Samjin Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Samjin Pharmaceutical Co., Ltd.'s total revenue was ₩79.63B, an increase of 6.73% from the same quarter last year. In Q2, Samjin Pharmaceutical Co., Ltd.'s net income was ₩6.10B. See Samjin Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 309.13B₩ 308.35B₩ 292.13B₩ 274.03B₩ 250.07B
Gross Profit
₩ 153.03B₩ 128.97B₩ 145.89B₩ 117.73B₩ 117.83B
Operating Expenses
₩ 128.35B₩ 97.33B₩ 126.39B₩ 94.55B₩ 83.92B
Depreciation and Amortization
₩ 19.82B₩ 17.40B₩ 16.61B₩ 9.82B₩ 7.36B
EBITDA
₩ 44.50B₩ 65.92B₩ 36.60B₩ 36.81B₩ 42.41B
Operating Income
₩ 24.68B₩ 31.64B₩ 19.50B₩ 23.18B₩ 33.91B
Other Income/Expenses
₩ -2.59B₩ 12.00B₩ -4.89B₩ 2.04B₩ 999.81M
Pretax Income
₩ 22.10B₩ 43.64B₩ 15.60B₩ 25.23B₩ 34.91B
Net Income
₩ 24.17B₩ 39.23B₩ 18.91B₩ 21.89B₩ 28.40B
Per Share Metrics
Basic EPS
₩ 1.96K₩ 3.11K₩ 1.46K₩ 1.73K₩ 2.31K
Diluted EPS
₩ 1.96K₩ 3.11K₩ 1.46K₩ 1.73K₩ 2.31K
Weighted Average Shares Outstanding
 12.25M 12.61M 12.95M 12.67M 12.30M
Weighted Average Shares Outstanding (Diluted)
 12.25M 12.61M 12.95M 12.67M 12.30M
Currency in KRW

Samjin Pharmaceutical Co., Ltd. Earnings and Revenue History